Background: Cap polyposis is a rarely encountered disease that describes multiple distinctive
Introduction
Cap polyposis is an inflammatory bowel disease first reported in 1985 by Williams et al. 1) in abstract form and concerned the histopathological findings of 15 cases. Consequently, this disease was not generally known until 2 clinical cases were described in 1993 by Campbell et al. 2) . To date, 18 cases have been reported in MEDLINE. This rare disease has characteristic clinical, endoscopic, and pathological features, and is therefore relatively easy to diagnose if a clinician or/and a pathologist is aware if it. The etiology of the disease is still unknown, and no specific or effective treatment has been established. Consequently, patients with cap polyposis generally suffer from this disease for a long time.
Recently, Oiya et al. 3) reported a patient with cap polyposis who was cured by
Helicobacter pylori eradication therapy prompting us to attempt this treatment for 3 cases of cap polyposis of long duration. All patients were remarkably improved.
Case Reports
Case 1: A 33-year-old woman was seen in 1993 for treatment of proctitis. She had suffered from mucous bloody stool for 2 years and been diagnosed with mucosal prolapse syndrome of the rectum. Past and family medical histories were unremarkable. Physical examination was normal except for pretibial pitting edema. Laboratory data showed hypoproteinemia (total protein 4.8 g/dl, albumin 2.8 g/dl). Markers of inflammation such as C-reactive protein (CRP) were normal. Colonoscopy showed multiple sessile polyps on the apices of the mucosal folds in the rectum (Fig. 1a) . The surface of these lesions was reddish and adhered by mucus. Multiple white specks were recognized in the area surrounding the polyps. The intervening mucosa was normal, and no diverticular disease was present. Microscopic findings of biopsy specimens revealed inflamed mucosa with elongated tortuous crypts attenuated towards the mucosal surface, and a granulation tissue "cap" on the surface of mucosa (Fig. 1b) . Culture of feces and serum anti-amoebic antibody were negative. On the basis of these findings, the patient was diagnosed with cap polyposis. Treatment with oral intake of 750 mg /day of metronidazole, or 40 mg/day of prednisolone and 3.0 g/day of salazosulphapyrisine were not effective. Home alimentation with digestive element and a suppository of a small dose of steroids (0.5-1.0 mg/day of betamethazone) were given along with the recommendation to avoid straining at defecation.
Her symptoms and endoscopic findings showed no remarkable change. Endoscopic treatment with endoscopic mucosal resection and endoscopic cauterization using argon plasma coagulation was attempted on in August 2000 resulting in improvement of symptoms and an increase in serum total protein (to total protein 6.0 mg/dl); however, symptoms recurred 3 months after endoscopic treatment and colonoscopy showed multiple sessile polyps attached with mucus in the rectum.
H. pylori infection was diagnosed by culture and histology of gastric biopsy specimens.
Immunohistochemical study using polyclonal anti-H. pylori antibody (DAKO Corp., Carpenteria, CA) showed no H. pylori in biopsy specimens obtained from inflammatory sessile polyps in the rectum (Fig. 1c) . After written informed consent, she received eradication therapy with 40 mg of rabeprazole, 1500 mg of amoxicillin, and 800 mg of clarithromycin daily for 7 days. This was begun in October 2002. Eradication therapy was successful, and her symptoms such as mucous bloody stool and pretibial edema were also immediately improved. After 3 months, colonoscopy revealed disappearance of multiple sessile polyps (Fig. 1d ). Serum total protein normalized to 7.0 g/dl, and the patient has had no recurrence for 18 months since eradication therapy of H. pylori.
Case 2:
A 50-year-old woman was referred to our hospital in September 1996 complaining of mucous bloody stool, tenesmus, and 8 kg weight loss. She had been suffering from mucous bloody stool for 10 months and had been diagnosed with ulcerative colitis. She had been treated with oral salazosulfapyridine and prednisolone, but her symptoms had become gradually more severe. Past and family medical histories were unremarkable. Physical examination was normal.
Laboratory data showed almost normal except hypoproteinemia (total protein 5.2 g/dl, albumin 3.3 g/dl); CRP was not increased. Colonoscopy revealed multiple sessile polyps on the apices of the mucosal folds in the rectum and the sigmoid colon. The surface of these lesions was reddish with adherent mucus, and multiple white specks in the area surrounding them (Fig. 2a) .
The intervening mucosa was normal, and no diverticular disease was observed. Microscopic findings of biopsy specimens showed inflamed mucosa with elongated tortuous crypts attenuated towards the mucosal surface. Culture of feces and serum anti-amoebic antibody were negative.
Alphaa-1-antitrypsin clearance test showed positive (428.9 mL/day). The progressive hypoproteinemia was thought to be due to protein losing enteropathy. On the basis of these findings, the patient was diagnosed with cap polyposis. Treatment with oral intake of 750 mg/day of metronidazole for 2 weeks was not effective. Avoidance of straining at defecation did not improve her symptoms. Total parenteral nutrition and enemas of 40 mg/day of prednisolone improved her symptoms and colonoscopic findings temporarily, but frequent mucous diarrhea recurred immediately after the resumption of eating. Surgical resection of the sigmoid colon was performed in November 1997 due to resistance to the conservative therapies. Unfortunately, her symptoms such as mucous bloody stool and tenesmus recurred 6 months after resection.
Colonoscopy showed multiple sessile polyps in the anal side of anastomotic portion, and multiple flat-topped protruding-type lesions in the oral site of anastomotic lesions (Fig. 2b ).
Microscopic findings of biopsy specimens revealed cap polyposis (Fig. 2c ). pylori was not detected in biopsy specimens that were taken from inflammatory polyps of the colon before eradication therapy by immunohistochemical study using anti-H. pylori antibody. enemas reduced her symptoms, and her serum protein gradually increased (total protein 7.7 g/dl).
However, she was later diagnosed with glaucoma and diabetes mellitus and steroids were discontinued. H. pylori infection was identified by gastric mucosal culture and histology.
Immunohistochemical study using anti-H. pylori antibody failed to show H. pylori in biopsy specimens obtained from the variform protruding mucosa in the rectum and the sigmoid colon.
After written informed consent, she received eradication therapy with 60 mg of lansoprazole, 1500 mg of amoxicillin, and 800 mg of clarithromycin taken daily for 7 days Eradication therapy was successful, and her symptoms were immediately improved. Colonoscopy at 3 months after eradication therapy revealed the disappearance of variform protruding mucosa (Fig. 3b) . She has remained well with no recurrence up to 15 months after eradication therapy.
Discussion
We have encountered 6 cases of cap polyposis including these 3 cases since 1983. The other 3 cases were reported previously as "unclassified colitis"
. We reviewed the 18 reported clinical cases diagnosed with cap polyposis 2)3)7)-17) and our 6 cases. The median age of the patients was 48.5 years (range, 12-76 years) showing that cap polyposis can occur over a wide range of age. The sex ratio favored women (men 6: women 18). The most frequent complaints were mucoid and/or bloody diarrhea. Laboratory data usually revealed hypoproteinemia due to protein-losing enteropathy. Shiomi et al. 18) reported a case of cap polyposis (included in reference 8) in which it was demonstrated that the extent of cap polyposis recognized on colonoscopy was congruous with excessive protein loss from the lesion, as shown on scintigraphy with human serum albumin labeled with Tc-99m DTPA. In two of our cases including a previously reported case 6) , protein-losing enteropathy was confirmed by α1-antitripsin clearance test, and hypoproteinemia improved in association with resolution of cap polyposis. The affected region of cap polyposis was generally recognized in the rectum and the sigmoid colon; however, protuberant lesions were observed from the rectum to the right side colon in 2 cases 3) 15) , and from the rectum to the descending colon in 4 cases 2)8)9)11)
.
The characteristic endoscopic findings are multiple sessile polyps attached with mucus on the apices of the mucosal folds, and the intervening mucosa was normal. Esaki et al. 13) analyzed endoscopic findings in 4 cases, and reported that endoscopic features were of two types: a semipedunculated type and a flat-topped protruding type. In our previously reported case 5) , the first colonoscopy showed multiple flushed edematous mucosa, and these findings developed into typical multiple sessile polyps after 4 months. Gehenot et al. 7) and Kajihara et al. 10) reported the same development in endoscopic findings. Based on these findings, multiple flushed edematous mucosa separated by normal mucosa are thought to be initial and/or mild endoscopic findings of cap polyposis. . However, no remarkable improvement was recognized in the remaining 6 cases.
Surgical resection of the affected colon was performed in 9 of 24 cases, but recurrence of symptoms and endoscopic findings within 12 months following the operation was recognized in 5 of these 9 cases (55.6%). Thus while surgical resection may be temporally effective, but recurrences are common. Endoscopic mucosal resection with cauterization using high-frequency current was administered in case 1. Temporal improvement of symptoms was recognized, but recurrence of symptoms and endoscopic findings was observed after 6 months.
This treatment has the same risk of recurrence as surgical resection of cap polyposis. Of interest, 4 cases of spontaneous resolution of cap polyposis have been reported 6)13)15)17)
Williams et al. 1) and Campbell et al. 2) suggested that chronic mechanical stimulation by abnormal rectosigmoid motility might be important in the pathogenesis of cap polyposis, based on its histological resemblance to mucosal prolapse syndrome. Oriuchi et al. 11) reported 2 cases of successful treatment of cap polyposis by avoidance of intraluminal trauma; one was cured by avoidance of straining at defecation, and another was resolved after double-barreled transverse colostomy. This report was thought to support the hypothesis of Williams et al. and Campbell et al. We recommended avoidance of straining at defecation in 3 of our cases including a previously reported case 6) , but this practice resulted in no remarkable improvement in any case. Total parenteral nutrition, which is expected to reduce mechanical stimulation of the digesta for the rectosigmoid mucosa, was performed in 2 of our cases including a previously reported case 6) , and symptoms and endoscopic findings improved temporally, but recurrence was immediately after resumption of eating. Based on these clinical courses, we consider that chronic mechanical stimulation might be a worsening factor for cap polyposis, and that the resemblance of histological findings of this disease to those of mucosal prolapse syndrome, such as the existing of elastin 2) , might be represent a secondary change in the development of cap polyposis.
On the basis of these our 3 cases and the case reported by Oiya et al. 3) , there appears to be . A possible role of transforming growth factor α and a relationship between hepatocyte growth factor and elongated gastric mucosa have been reported 22)23) . These growth factors are related to cytokine networks, which are influenced by the immune response to inflammation caused by H. pylori infection 24) .
Characteristic histological findings of cap polyposis include inflamed mucosa with elongated tortuous crypts and inflammatory granulomatous tissue on the surface of the mucosa. Multiple polypoid lesions are thought to be composed of elongated tortuous crypts, which resemble the histological finding of Menetrier's disease. Therefore, we suggest that cap polyposis might be hypertrophic change of the large intestine influenced by systemic immune stimulation due to persistent H. pylori infection.
The effectiveness of metronidazole for cap polyposis is inconsistent. Gehenot et al. 7) reported a case of cap polyposis occurring in the postoperative course of pelvic surgery, and supposed that infection by some unknown microorganism was related to the occurrence of cap polyposis because oral intake of metronidazole was temporarily effective to reduce symptoms. 
